CryoCor files against CryoCath in regulation patent dispute
This article was originally published in Clinica
CryoCor and CryoCath, competitors in the cardiac arrhythmia market, are now locked in a rivalry in court. CryoCor has filed two patent infringement lawsuits against CryoCath, one in the US district court of Delaware and one filed in Canada, claiming that the latter's products infringe patents relating to its cardiac cryoablation system. San Diego, California-based CryoCor is seeking monetary damages and injunctions to prohibit CryoCath from selling its products in the US and Canada. The action comes as a countersuit against a previous claim made by CryoCath (Montreal, Canada) in October 2007, alleging that CryoCor had infringed on patents covering CryoCath's console technology. Both companies specialise in manufacturing minimally invasive catheter systems designed to treat cardiac arrhythmias with the use of cryoablation.
You may also be interested in...
Private Company Edition: Venture capital financings didn’t take a break during Thanksgiving week. In addition to the $800m Resilience raised to fund manufacturing services, SomaLogic closed a $121m series A round to fund its proteomic tools for drug discovery and diagnostics development.
The $250m deal adds A&E Medical’s sternal sutures, cable systems, and rigid fixation systems to Zimmer Biomet’s Dental, Spine & Craniomaxillofacial and Thoracic business.
The Phase III clinical trial showed a noticeable placebo effect compared with OV101.